Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Family Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine), Fellow Member Emergency Medicine, Diplomate Emergency Medicine
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine), Fellow Member Emergency Medicine, Diplomate Emergency Medicine
Consultant Physician
M.B.B.S, F.C.P.S. (Medicine), Postgraduate Diploma in Diabetes (UK), MRCP (Endocrinology and Dibetes)
Consultant Physician
M.B.B.S, F.C.P.S. (Medicine), Postgraduate Diploma in Diabetes (UK), MRCP (Endocrinology and Dibetes)
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Consultant Physician
M.B.B.S., Diploma In Cardiac Rehabilitation, M.C.P.S
General Physician
MBBS, MCPS (Family Medicine), MRCGP 1 [INT] SA
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures